previous compound ID: 632 next compound
InChIKey: FQZYTYWMLGAPFJ-OQKDUQJOSA-N
SMILES: CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"SD Macknight" "JW Hanrahan" "E Matthes" "DY Thomas" "GW Carlile" "J Liao" "R Robert" "J Goepp" "D Rotin" "B Kus"

chemical graph of compound 632





CID is 2733525
synonyms found at PubChem are:
Tamoxifen citrate, 54965-24-1, Istubal, Tamoxifen (Citrate), Zitazonium, UNII-7FRV7310N6, I.C.I. 46474 citrate, Tamoxifen citrate salt, ICI 46474, Farmifeno, Ginarsan, Jenoxifen, Ledertam, Nourytan, Noxitem, Oncotam, Tafoxen, Tamofen, Tamoplex, Tamoxasta, Tamoxifen Citrate (Nolvadex), Terimon, Zynoplex, Emblon, Nolgen, Noltam, Zemide, Genox, Tamax, Taxus, Tamox-Puren, 7FRV7310N6, Z-Tamoxifen citrate, NSC180973, NCGC00024928-06, CAS-54965-24-1, DSSTox_CID_1301, N,N-Dimethyl-2-(p-(1,2-diphenyl-1-butenyl)phenoxy)ethylamine citrate, DSSTox_RID_76068, Ethylamine, 2-(p-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethyl-, citrate (Z)-, DSSTox_GSID_21301, CCRIS 6718, Caditam, EINECS 259-415-2, ICI 46,474, 7244-97-5, Ethanamine, 2-(4-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethyl-, (Z)-, 2-hydroxy-1,2,3-propanetricarboxylate, SMR000677949, SR-01000075523, citro; tamoxifen, trans-1-(p-beta-Dimethylaminoethoxyphenyl)-1,2-diphenylbut-1-ene citrate, (Z)-2-(p-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethylamine citrate (1:1), 2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid, Prestwick_458, Tamoxifen citrate [USAN:USP:JAN], Tamoxifen (Nolvadex), Tamoxifen Citrate,(S), Tamoxifen, citrate salt, AC1MBZ3O, Lopac-T-9262, CHEMBL786, SCHEMBL6365, MLS001055370, MLS002154210, ARONIS23853, SPECTRUM1500557, Nolvadex (TN) (AstraZeneca), DTXSID8021301, Tamoxifen citrate (JP17/USP), HMS500M20, Tamoxifen citrate salt, >=99%, FQZYTYWMLGAPFJ-OQKDUQJOSA-N, HMS1568M14, HMS1921C13, HMS2092K17, HMS2095M14, HMS2232E08, HMS3263B08, HMS3712M14, Pharmakon1600-01500557, (2-{4-[1,2-diphenylbut-1-en-1-yl]phenoxy}ethyl)dimethylamine; 2-hydroxypropane-1,2,3-tricarboxylic acid, (Z)-(2-(4-(1,2-Diphenylbut-1-enyl)phenoxy)ethyl)dimethylammonium dihydrogen 2-hydroxypropane-1,2,3-tricarboxylate, 10540-29-1 (Parent), 2-{4-[(1Z)-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine 2-hydroxypropane-1,2,3-tricarboxylate (salt), Ethanamine, 2-(4-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethyl, (Z)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1), hydroxypropane-1,2,3-tricarboxylate, Tox21_110938, Tox21_202070, Tox21_300274, Tox21_501203, CCG-39629, MFCD00058321, NSC757345, s1238, s1972, SBB080554, AKOS005111126, Tox21_110938_1, CS-1852, KS-5046, LP01203, NSC-180973, NSC-757345, NCGC00016206-01, NCGC00016206-02, NCGC00016206-03, NCGC00016206-04, NCGC00016206-05, NCGC00016206-06, NCGC00024928-02, NCGC00024928-23, NCGC00094450-01, NCGC00094450-02, NCGC00094450-03, NCGC00094450-04, NCGC00254000-01, NCGC00259619-01, NCGC00261888-01, CPD000677949, HY-13757, KB-80806, LS-68202, M936, SAM002564256, SC-13399, BCP0726000223, AB0006810, AB2000015, EU-0101203, (Z)-2-(4-(1,2-diphenylbut-1-enyl)phenoxy), D00966, J10303, K-9859, T 9262, 965T241, Q-201776, SR-01000075523-1, SR-01000075523-3, SR-01000075523-5, SR-01000075523-6, SR-01000075523-10, (Z)-1-(4-Dimethylaminoethoxyphenyl)-1,2-diphenyl-1-butene Citrate, Tamoxifen citrate, European Pharmacopoeia (EP) Reference Standard, (Z)-2-[4-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethanamine citrate, Tamoxifen citrate, United States Pharmacopeia (USP) Reference Standard, (Z)-2-[ p-(1,2-Diphenyl-1-butenyl)phenoxy]- N, N-dimethylethylamine citrate (1:1), (Z)-2-[4-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethyl-ethanamine cirtrate (1:1), Tamoxifen citrate for performance test, European Pharmacopoeia (EP) Reference Standard, (Z)-2-(4-(1,2-diphenylbut-1-en-1-yl)phenoxy)-N,N-dimethylethan-1-amine 2-hydroxypropane-1,2,3-tricarboxylate, (Z)-2-(4-(1,2-diphenylbut-1-enyl)phenoxy)-N,N-dimethylethanamine 2-hydroxypropane-1,2,3-tricarboxylate, {2-[4-((1Z)-1,2-diphenylbut-1-enyl)phenoxy]ethyl}dimethylamine, 2-hydroxypropa ne-1,2,3-tricarboxylic acid, 2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine; 2-hydroxypropane-1,2,3-tricarboxylic acid, Ethanamine, 2-(4-((1Z)-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1), Ethanamine,2-diphenyl-1-butenyl)phenoxy]-N,N-dimethyl-, (Z)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1), Tamoxan, Tamoxene, Tamoxin, Tamox, 2-{4-[(1Z)-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine 2-hydroxypropane-1,2,3-tricarboxylate